Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-17

Clinical Trial Update: Phase 2 Study IV QUZYTTIR™ (Cetirizine Hydrochloride Injection) vs V Diphenhydramine [Phase 2]

View source ↗

Summary

A Phase 2 study comparing QUZYTTIR™ (cetirizine hydrochloride injection) to diphenhydramine in oncology patients receiving chemotherapy has completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diphenhydramine (diphenhydramine)
  • QUZYTTIR (cetirizine hydrochloride)

Snippet

Sponsor: TerSera Therapeutics LLC | Conditions: Oncology Patients Receiving Chemotherapy | Phase 2 | Status: COMPLETED | Results posted: 2022-05-17